- (PLX AI) - Coloplast shares declined after Carnegie downgraded the stock to sell, saying valuation was too high.
- • Coloplast is likely to keep its guidance unchanged in its upcoming earnings report, but the year may end up on a weaker note and consensus may be too high, Carnegie said
- • Price target DKK 1,015 implies 10% downside